Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose

European Journal of Pharmaceutical Sciences

Volumn 34, Issue 4-5, 2008, Pages 274-280

  Yi, Tao ^a   Wan, Jiangling ^a   Xu, Huibi ^a   Yang, Xiangliang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Controlled release; Hydroxypropylmethylcellulose; Poorly soluble drugs; Self microemulsifying; Spray drying

Indexed keywords

CREMOPHOR; HYDROXYPROPYLMETHYLCELLULOSE; LABRASOL; METHYLCELLULOSE; NIMODIPINE; OLEIC ACID ETHYL ESTER;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; IN VITRO STUDY; MICROEMULSION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; KINETICS; LIPIDS; METHYLCELLULOSE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NIMODIPINE; OLEIC ACIDS; ORGANIC CHEMICALS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POWDER DIFFRACTION; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; VISCOSITY;

EID: 47249128905     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.04.010     Document Type: Article

References (23)

1. Abdalla A., and Mader K. Preparation and characterization of a self-emulsifying pellet formulation. Eur. J. Pharm. Biopharm. 66 (2007) 220-226
2. Attama A.A., Nzekwe I.T., Nnamania P.O., Adikwua M.U., and Onugu C.O. The use of solid self-emulsifying systems in the delivery of diclofenac. Int. J. Pharm. 262 (2003) 23-28
3. Campos-Aldrete M.E., and Villafuerte-Robles L. Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm. 43 (1997) 173-178
4. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Deliv. Rev. 11 (1993) 37-57
5. Ford J.L., Rubinstein M.H., McCaul F., Hogan J.E., and Edgar P.J. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int. J. Pharm. 40 (1987) 223-234
6. Franceschinis E., Voinovich D., Grassi M., Perissutti B., Filipovic-Grcic J., Martinac A., and Meriani-Merlo F. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int. J. Pharm. 291 (2005) 87-97
7. Grunenberg A., Keil B., and Henck J.O. Polymorphism in binary mixture, as exemplified by nimodipine. Int. J. Pharm. 118 (1995) 11-21
8. He Z.G., Zhong D.F., Chen X.Y., Liu X.H., Tang X., and Zhao L.M. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation. Eur. J. Pharm. Sci. 21 (2004) 487-491
9. Kim C.K., Shin H.J., Yang S.G., Kim J.H., and Oh Y.K. Once-a-day oral dosing regimen of cyclosporin a: combined therapy of cyclosporin a premicroemulsion concentrates and enteric coated solid-state premicroemulsion concentrates. Pharm. Res. 18 (2001) 454-459
10. Korsmeyer R.W., Gurny R., Doelker E., Buri P., and Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15 (1983) 25-35
11. Langer R., and Peppas N.A. Chemical and physical structure of polymers as carriers for controlled release of bioactive agents: a review. Rev. Macromol. Chem. Phys. C 23 (1983) 61-126
12. Langley M.S., and Sorkin E.M. Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic. Drugs 37 (1989) 669-699
13. Li C.L., Martini L.G., Ford J.L., and Roberts M. The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol. 57 (2005) 533-546
14. Nazzal S., Nutan M., Palamakula A., Shah R., Zaghloul A.A., and Khan M.A. Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int. J. Pharm. 240 (2002) 103-114
15. Nazzal S., and Khan M.A. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int. J. Pharm. 315 (2006) 110-121
16. Newton J.M., Petersson J., Podczeck F., Clarke A., and Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci. 90 (2001) 987-995
17. Newton J.M., Pinto M.R., and Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization. Eur. J. Pharm. Sci. 30 (2007) 333-342
18. Panomsuk S.P., Hatanaka T., Aiba T., Katayama K., and Koizumi T. A study of the hydrophilic cellulose matrix: effect of indomethacin and a water soluble additive on swelling properties. Int. J. Pharm. 126 (1995) 147-153
19. Serratoni M., Newton J.M., Booth S., and Clarke A. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur. J. Pharm. Biopharm. 65 (2007) 94-98
20. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 (2001) 139-157
21. Tahara K., Yamamoto K., and Nishihata T. Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropyl methylcellulose sustained release tablets. Int. J. Pharm. 133 (1996) 17-27
22. Tuleu C., Newton J.M., Rose J., Euler D., Saklatvala R., Clarke A., and Booth S. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J. Pharm. Sci. 93 (2004) 1495-1502
23. Tu Q.R., Zhu Y., and Zhu J.B. Study on formulation of nimodipine self-microemulsifying drug delivery system. Chin. Pharm. J. 40 (2005) 43-46